---
title: "Trastuzumab and Rituximab Subcut"
ocid: "ocds-r6ebe6-0000812947"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000812947"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000812947.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000812947.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)"
published: "2026-03-23"
---

# Trastuzumab and Rituximab Subcut

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)  
Current stage: Award  
OCID: ocds-r6ebe6-0000812947

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000812947)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000812947.json)

## Summary

The Common Services Agency, known as NHS National Services Scotland (NSS), is procuring the supply of Trastuzumab and Rituximab Subcut for NHS Scotland, under a process initiated as a tender. The procurement falls within the health industry category and is based in the UK, particularly for all entities governed by the NHS Scotland Act 1978. The procurement method employed does not involve prior publication of a call for competition due to intellectual property rights protection. The tender concluded with an award to Roche Products Ltd, valued at £20,957,710, and spans a ten-month duration with potential extensions. The award date was 4 November 2025, with a contract commencement following suit, under the procurement stage of 'Award'.

This procurement of medicinal goods, specifically the Trastuzumab and Rituximab Subcut, offers opportunities for businesses specialising in pharmaceuticals with exclusive rights and a capability to supply on a large scale. Companies with existing frameworks for intellectual property-sensitive products are ideally positioned to leverage such contracts, particularly given the 'limited' procurement method allowing for streamlined access. With NSS consistently involved in large-scale procurement processes, entities with expertise in the healthcare sector can explore potential partnerships and contribute to anticipated growth avenues. The contract not only highlights potential for expansion but also assures continuity through well-structured extensions, bolstering business growth for qualified pharmaceutical companies, especially those seeking extensive engagement within public health frameworks.

## Notice

Supply of Trastuzumab and Rituximab Subcut to NHS Scotland.

### Lot Information

Lot 1

Supply of Trastuzumab and Rituximab Subcut to NHS Scotland. The Authority has awarded this framework as a single supplier framework per line to one (1) Framework Participant.

### Procurement Information

The medicine to be awarded to the framework agreement is protected by exclusive rights, including intellectual property rights, in line with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR552291 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 23 Mar 2026 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 4 Nov 2025 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £20,957,710 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS) |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | ROCHE PRODUCTS |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 23 Mar 2026 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR552291
- 4 Nov 2025 at 00:00 - Award - OJEU - F15 - Voluntary Ex Ante Transparency Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=NOV542760

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=NOV542760
  Trastuzumab and Rituximab Subcut - Supply of Trastuzumab and Rituximab Subcut to NHS Scotland.
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR552291
  Trastuzumab and Rituximab Subcut - Supply of Trastuzumab and Rituximab Subcut to NHS Scotland.

## Notice URLs

- http://
- http://www.nss.nhs.scot/browse/procurement-and-logistics
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000812947

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000812947. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000812947.json.